Smarter, Faster Angiogenesis Assessment with Automated 3D Organ-on-Chip Analysis

April 2026

Three-dimensional organ-on-chip (OoC) platforms provide physiologically relevant models for angiogenesis research, enabling clearer insights into vessel formation and drug responses. Yet their intricate microfluidic architecture requires specialized imaging for reliable, high-quality data. A dedicated, automated imaging workflow ensures consistent, high-resolution data that accelerate and strengthen your drug-development decisions.